Picture Stier Group MIXiii Lifescience Healthtech Conference 650x100px
Document › Details

Merck KGaA. (12/15/17). "Press Release: Petra Wicklandt Appointed Head of Corporate Affairs at Merck". Darmstadt.

Region Region ALL
Organisations Organisation Merck KGaA
  Group Merck (DE) (Group)
  Organisation 2 University of Mainz (Johannes Gutenberg University)
Products Product pharmaceutical
Person Person Wicklandt, Petra (Merck (DE) 201801– Head of newly created Corporate Affairs unit joined Merck 1994)

Merck, a leading science and technology company, today announced that Petra Wicklandt (53) will take over the leadership of the newly created Corporate Affairs unit as of January 1, 2018. She will report to Stefan Oschmann, Executive Board Chairman & CEO of Merck.

“I am very pleased that Petra Wicklandt, an experienced executive from within the company, will represent Merck vis-ŕ-vis politicians, associations and non-governmental organizations,” said Stefan Oschmann. Corporate Affairs consolidates the government and public affairs of the three business sectors as well as the Corporate Responsibility and Global Health activities of the Group. In the future, Corporate Affairs offices in Berlin, Brussels, Washington, Boston as well as Beijing and Shanghai will bolster Merck’s presence in the regions. The objectives of the new Group function are to provide even more efficient support to the businesses as they implement their objectives and to better steer Group-wide initiatives.

Petra Wicklandt joined Merck in 1994 and most recently served as Head of Global Chemical and Pharmaceutical Development. Her work focused on building a high-performance organization for the development of manufacturing methods and quality control for new active ingredients and dosage forms. Wicklandt studied pharmacy and earned a doctorate at the Johannes Gutenberg University of Mainz.

For more information, please contact Friederike Segeberg
+49 6151 72-6328

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to to register online, change your selection or discontinue this service.

About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Record changed: 2023-06-05


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Merck (DE) (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x300px

» top